Skip to Main Content

Here you can browse the complete list of publications for PLCO

Studies
Publication Year
Title PubMed Id Authors Journal Abbreviation Year Studies
Meat, meat cooking methods and preservation, and risk for colorectal adenoma. 16140978 Sinha R, Peters U, Cross AJ, Kulldorff M, Weissfeld JL, Pinsky PF, Rothman N, Hayes RB Cancer Res. 2005 PLCO
Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. 16368945 Oken MM, Marcus PM, Hu P, Beck TM, Hocking W, Kvale PA, Cordes J, Riley TL, Winslow SD, Peace S, Levin DL, Prorok PC, Gohagan JK, PLCO Project Team J. Natl. Cancer Inst. 2005 PLCO
Genetic variation in the HSD17B1 gene and risk of prostate cancer. 16311626 Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB, Altshuler D, Andriole G, Berg C, Boeing H, Burtt NP, Bueno-de-Mesquita B, Calle EE, Cann H, Canzian F, Chen YC, Crawford DE, Dunning AM, Feigelson HS, Freedman ML, Gaziano JM, Giovannu… PLoS Genet. 2005 PLCO
CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma. 15731166 Hou L, Chatterjee N, Huang WY, Baccarelli A, Yadavalli S, Yeager M, Bresalier RS, Chanock SJ, Caporaso NE, Ji BT, Weissfeld JL, Hayes RB Carcinogenesis 2005 PLCO
Effects of false-positive prostate cancer screening results on subsequent prostate cancer screening behavior. 15668495 Ford ME, Havstad SL, Demers R, Cole Johnson C Cancer Epidemiol. Biomarkers Prev. 2005 PLCO
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. 16341085 Hunter DJ, Riboli E, Haiman CA, Albanes D, Altshuler D, Chanock SJ, Haynes RB, Henderson BE, Kaaks R, Stram DO, Thomas G, Thun MJ, Blanché H, Buring JE, Burtt NP, Calle EE, Cann H, Canzian F, Chen YC, Colditz GA, Cox DG, Dunning AM, Feigelson HS, Fr… Nat. Rev. Cancer 2005 PLCO
A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. 16279272 Ford ME, Havstad SL, Davis SD Clin Trials 2004 PLCO
Risk behaviours and benign prostatic hyperplasia. 15180615 Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, Reding D, Huang WY, Hayes RB BJU Int. 2004 PLCO
Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. 15066918 Peters U, Hayes RB, Chatterjee N, Shao W, Schoen RE, Pinsky P, Hollis BW, McGlynn KA, Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team Cancer Epidemiol. Biomarkers Prev. 2004 PLCO
The economic impact of false-positive cancer screens. 15598770 Lafata JE, Simpkins J, Lamerato L, Poisson L, Divine G, Johnson CC Cancer Epidemiol. Biomarkers Prev. 2004 PLCO
Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma. 15598778 Peters U, Chatterjee N, Yeager M, Chanock SJ, Schoen RE, McGlynn KA, Church TR, Weissfeld JL, Schatzkin A, Hayes RB Cancer Epidemiol. Biomarkers Prev. 2004 PLCO
Calcium intake and colorectal adenoma in a US colorectal cancer early detection program. 15531687 Peters U, Chatterjee N, McGlynn KA, Schoen RE, Church TR, Bresalier RS, Gaudet MM, Flood A, Schatzkin A, Hayes RB Am. J. Clin. Nutr. 2004 PLCO
The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise. 15283897 Andriole GL, Reding D, Hayes RB, Prorok PC, Gohagan JK, PLCO Steering Committee Urol. Oncol. 2004 PLCO
False-positive cancer screens and health-related quality of life. 15525861 McGovern PM, Gross CR, Krueger RA, Engelhard DA, Cordes JE, Church TR Cancer Nurs 2004 PLCO
Design of a case management approach to enhance cancer screening trial retention among older African American men. 15448286 Ford ME, Randolph V, Hopkins-Johnson L, Eason SL, Havstad S, Jankowski M, Swanson GM, Johnson CC, Vernon SW J Aging Health 2004 PLCO
Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure. 15342446 Sit AS, Modugno F, Hill LM, Martin J, Weissfeld JL Cancer Epidemiol. Biomarkers Prev. 2004 PLCO
Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial. 15265970 Taylor KL, Shelby R, Gelmann E, McGuire C J. Natl. Cancer Inst. 2004 PLCO
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: biopsy rates and cancer characteristics of initial (T0) screen. Andriole GL, Pinsky PF, Levin DL, Gelmann EP, Crawford ED, Reding DJ, Prorok PC, Gohagan J. Urol. 2004 PLCO
Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence. 12540500 Ford ME, Havstad SL, Flickinger L, Johnson CC Cancer Epidemiol. Biomarkers Prev. 2003 PLCO
Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. 12727673 Pinsky PF, Kramer BS, Reding D, Buys S, PLCO Project Team Am. J. Epidemiol. 2003 PLCO